Volver a Agenda
Session Chair(s)
Romi Singh, PHD
Professor of Practice, Regulatory Sciences
Northeastern University, United States
Tomas Salmonson, DrMed, PHD
Critical Path Institute, Netherlands
Speaker(s)
Contribution of Asia in Execution of Global Clinical Trials
Yoshimasa Shimoto, PHD
Daiichi Sankyo Co., Ltd., Japan
Vice President, Asia Development (Region Head)
Asia's Role in Drug Development - an European Perspective
Tomas Salmonson, DrMed, PHD
Critical Path Institute, Netherlands
Concept of Adaptive Licensing and Its Feasibility for a New Pathway of Drug Development from the Regional and Global Regulators' Perspective
Raymond S.B. Chua, MD, MBA, MPH, FRCP
Ministry of Health, Singapore
Deputy Director of Medical Services, Health Regulation Group
¿Tiene una cuenta?